The ACE I/D polymorphism in US adults: Limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity

American Journal of Hypertension

Volumn 25, Issue 2, 2012, Pages 209-215

  Ned, Renée M ^a   Yesupriya, Ajay ^a   Imperatore, Giuseppina ^b   Smelser, Diane T ^a,c   Moonesinghe, Ramal ^d   Chang, Man Huei ^a   Dowling, Nicole F ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c American Society of Human Genetics Fellow   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

ACE; blood pressure; cross sectional studies; genetic susceptibility; hypertension; National Health and Nutrition Examination Survey; polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; BLOOD PRESSURE VARIABILITY; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; GENETIC ASSOCIATION; HEALTH SURVEY; HISPANIC; HUMAN; HYPERTENSION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTENSION; INDEL MUTATION; MALE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84856035757     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.182     Document Type: Review

References (40)

1. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol 2007; 22:176-184. (Pubitemid 46581192)
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346. (Pubitemid 20370444)
3. Danser AH, Batenburg WW, van den Meiracker AH, Danilov SM. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacol Ther 2007; 113:607-618. (Pubitemid 46365959)
4. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20:484-492. (Pubitemid 30086107)
5. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592. (Pubitemid 28029652)
6. Mizuiri S, Hemmi H, Kumanomidou H, Iwamoto M, Miyagi M, Sakai K, Aikawa A, Ohara T, Yamada K, Shimatake H, Hasegawa A. Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 2001; 60:1124-1130. (Pubitemid 34205813)
7. Suehiro T, Morita T, Inoue M, Kumon Y, Ikeda Y, Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 2004; 115:91-96. (Pubitemid 39010922)
8. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98:1123-1133. (Pubitemid 43948098)
9. Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999; 22:59-62. (Pubitemid 29214805)
10. Norton GR, Brooksbank R, Woodiwiss AJ. Gene variants of the renin-angiotensin system and hypertension: from a trough of disillusionment to a welcome phase of enlightenment? Clin Sci 2010; 118:487-506.
11. Ji LD, Zhang LN, Shen P, Wang P, Zhang YM, Xing WH, Xu J. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a metaanalysis. J Hypertens 2010; 28:419-428.
12. Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010; 12:17-25.
13. Sõber S, Org E, Kepp K, Juhanson P, Eyheramendy S, Gieger C, Lichtner P, Klopp N, Veldre G, Viigimaa M, Döring A, Putku M, Kelgo P, Shaw-Hawkins S, Howard P, Onipinla A, Dobson RJ, Newhouse SJ, Brown M, Dominiczak A, Connell J, Samani N, Farrall M, Caulfield MJ, Munroe PB, Illig T, Wichmann HE, Meitinger T, Laan M; Kooperative Gesundheitsforschung in der Region Augsburg Study; HYPertension in ESTonia Study; MRC British Genetics of Hypertension Study. Targeting 160 candidate genes for blood pressure regulation with a genomewide genotyping array. PLoS ONE 2009; 4:e6034.
14. Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, Ogata J, Ogihara T. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation 2000; 101:2060-2065. (Pubitemid 30233169)
15. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
16. NHANES III Data Files. . National Center for Health Statistics, Centers for Disease Control and Prevention: Hyattsville, MD.
17. NHANES Genetic Data. . National Center for Health Statistics, Centers for Disease Control and Prevention: Hyattsville, MD.
18. Chang MH, Lindegren ML, Butler MA, Chanock SJ, Dowling NF, Gallagher M, Moonesinghe R, Moore CA, Ned RM, Reichler MR, Sanders CL, Welch R, Yesupriya A, Khoury MJ; CDC/NCI NHANES III Genomics Working Group. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol 2009; 169:54-66.
19. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics: Hyattsville, MD, 1994. (Vital and Health Statistics, Series 1: Programs and Collection Procedures, no. 32) (DHHS publication no. (PHS) 94-1308) (GPO no. 017-022-01260-0). .
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1:S62-S69.
21. Binder D. On the variance of asymptotically normal estimators from complex surveys. Int Stat Rev 1983; 51:279-292.
22. Woodruff R. A simple method for approximating the variance of a complicated estimate. J Am Stat Assoc 1971; 66:411-414.
23. Using the Sampling Design in Logistic Regression Analysis of NCHS Survey Data-Some Applications. Proceedings of the Survey Research Methods Section, American Statistical Association (ASA). American Statistical Association: Alexandria, VA , pp. 327-332.
24. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006; 164:609-614. (Pubitemid 44453487)
25. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106:9362-9367.
26. Chung CM, Wang RY, Chen JW, Fann CS, Leu HB, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Jong YS, Lin SJ, Chen YT, Pan WH. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J 2010; 10:537-544.
27. Abdollahi MR, Huang S, Rodriguez S, Guthrie PA, Smith GD, Ebrahim S, Lawlor DA, Day IN, Gaunt TR. Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women's Heart and Health Study (BWHHS). Dis Markers 2008; 24:11-17. (Pubitemid 350174566)
28. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, Connell JM, Bennett F, McFarlane-Anderson N, Lathrop GM, Cardon LR. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001; 10:1077-1084. (Pubitemid 32447785)
29. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003; 12:859-867. (Pubitemid 36504028)
30. Niu W, Qi Y, Gao P, Zhu D. Association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011; 12:8-14.
31. Bamshad M. Genetic influences on health: does race matter? JAMA 2005; 294:937-946. (Pubitemid 41215463)
32. Tang H, Quertermous T, Rodriguez B, Kardia SL, Zhu X, Brown A, Pankow JS, Province MA, Hunt SC, Boerwinkle E, Schork NJ, Risch NJ. Genetic structure, selfidentified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005; 76:268-275. (Pubitemid 40129553)
33. Yang N, Li H, Criswell LA, Gregersen PK, Alarcon-Riquelme ME, Kittles R, Shigeta R, Silva G, Patel PI, Belmont JW, Seldin MF. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 2005; 118:382-392. (Pubitemid 43101691)
34. Espeland MA, Kumanyika S, Wilson AC, Reboussin DM, Easter L, Self M, Robertson J, Brown WM, McFarlane M; TONE Cooperative Research Group. Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes. Am J Epidemiol 2001; 153:996-1006. (Pubitemid 32423786)
35. Bentley B. A review of methods to measure dietary sodium intake. J Cardiovasc Nurs 2006; 21:63-67.
36. Pereira TV, Nunes AC, Rudnicki M, Yamada Y, Pereira AC, Krieger JE. Metaanalysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008; 51:778-783. (Pubitemid 351301535)
37. Liu K, Liu J, Huang Y, Liu Y, Lou Y, Wang Z, Zhang H, Yan S, Li Z, Wen S. Alphaadducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls. PLoS One 2010; 5:e13057.
38. Liu K, Liu Y, Liu J, Wang Z, Lou Y, Huang Y, Niu Q, Gu W, Zhu X, Wen S. α-Adducin Gly460Trp polymorphism and essential hypertension risk in Chinese: a metaanalysis. Hypertens Res 2011; 34:389-399.
39. Sookoian S, Gianotti TF, González CD, Pirola CJ. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 2007; 25:5-13. (Pubitemid 44885657)
40. Tomaszewski M, Debiec R, Braund PS, Nelson CP, Hardwick R, Christofidou P, Denniff M, Codd V, Rafelt S, van der Harst P, Waterworth D, Song K, Vollenweider P, Waeber G, Zukowska-Szczechowska E, Burton PR, Mooser V, Charchar FJ, Thompson JR, Tobin MD, Samani NJ. Genetic architecture of ambulatory blood pressure in the general population: insights from cardiovascular gene-centric array. Hypertension 2010; 56:1069-1076.